18 - 20 October 2018
Copenhagen, Denmark

Promotion and Sponsorship

Industry Sponsored Symposia

 

DAY 1 Thursday, 18 October 2018

17:00- 18:30 INDUSTRY SPONSORED SYMPOSIUM 1:
News in molecular allergology – Applying precision medicine in clinical practice

Chairs: Philippe Eigenmann, Switzerland - Magnus Borres, Sweden

Tree nut allergen component sensitization across Europe – lessons learnt from the Pronut study
Philippe Eigenmann, Switzerland

Meta analyses of the clinical utility of peanut and hazelnut components in allergy diagnosis
Caroline Nilsson, Sweden

LTP allergies - prevalence, diagnosis and clinical implications
Olga Luengo, Spain

IgE and IgG4 to allergen components for inclusion and monitoring of peanut OIT
Brian Vickery, United States

Room:
Carstensen

Supported by
ThermoFisher



DAY 2 Friday, 19 October 2018

12:00- 13:00 INDUSTRY LUNCH SYMPOSIUM:
Peanut Allergy in a Changing World

Chair: Gideon Lack, United Kingdom

Chair’s welcome and introduction peanut allergy landscape before and after LEAP
Gideon Lack, United Kingdom

Recent research advances in the management of peanut allergy
Kirsten Beyer, Germany

Understanding clinical trial design and terminology in food allergy
Montserrat Fernández -Rivas, Spain

Q&A
Room:
Tivoli Congress Hall

Supported by
Aimmune

13:00- 14:15
INDUSTRY SPONSORED SYMPOSIUM 2:
Nutritional strategies targeting the gut microbiota & its role in early life allergy development

Food allergy, where are we now?
Ulrich Wahn, Germany

The role of nutrition in gut microbiota development and early life immunity
Glenn Gibson, United Kingdom

Translating the latest scientific insights for the dietary management of allergy into clinical practice
Carina Venter, United States
Room:
Carstensen

Supported by
Nutricia


16:30- 18:00 INDUSTRY SPONSORED SYMPOSIUM 3:
Peanut allergy in children: managing patients’ and caregivers’ expectations

Chairs: Antonella Muraro, Italy - David Fleisher, United States

Welcome and Introductions
Antonella Muraro, Italy

Burden of Peanut Allergy Disease in Europe – can we identify patients at risk of severe reactions?
Paul Turner, United Kingdom

How the standard of care in peanut allergy may evolve?
Katharina Blümchen, Germany

Overview of investigational epicutaneous immunotherapy for peanut allergy
David Fleischer, United States

Summary
David Fleisher, United States

Faculty Panel Q&A

All faculty
Room:
Vandsalen

Supported by
DBV


DAY 3 Saturday, 20 October 2018

11:30- 12:45

INDUSTRY SPONSORED SYMPOSIUM 4:
The role of the gut microbiota in food allergic disease and implications for nutritional management

Chair: Kirsten Beyer, Germany

Gut microbiota dysbiosis and modulation in food allergy
Eva Untersmayr, Austria

Pre-, pro- and synbiotics in food allergy management – practical advice and case studies
Carina Venter, United States

Room:
Carstensen

Supported by
Nutricia
 


Privacy Policy - disclaimer

EAACI recently updated its privacy policy and would like to highlight some key bits of information with you.

  • EAACI does not distribute, share or sell your information;
  • For technical and administrative purposes some information that can be used to identify you may be forwarded to third parties. For example, to process your registration for the EAACI Annual Congress and other EAACI events;
  • The Academy may also send you e-mail messages with news from the society. If you would like to no longer receive them, you can unsubscribe at any time by using the unsubscribe link in any of our communications;
  • You may also update your preferences or your profile information at any time by contacting us.

To continue please confirm that you agree with our updated privacy policy.

Thank you!

You have successfully agreed the new privacy policy – disclaimer.

Thank you!

You disagreed with the new privacy policy – disclaimer and your feedback will be reviewed as soon as possible.

Agree & Continue
Disagree
Send feedback
Cancel